BLRX

BioLineRX
BLRX

Overview Fund Activity

24 hedge funds and large institutions have $5.65M invested in BioLineRX in 2016 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 4 closing their positions.

Holders
24
Holders Change
-2
Holders Change %
-7.69%
% of All Funds
0.64%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
5
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Morgan Stanley
1
Morgan Stanley
New York
$387K
2
UBS Group
2
UBS Group
Switzerland
$29K
3
ARTA
3
A.R.T. Advisors
New York
$20K
4
CCB
4
Cutter & Co Brokerage
Missouri
$20K
5
Alyeska Investment Group
5
Alyeska Investment Group
Illinois
$490K

Top Sellers

1
VKH
1
Virtu KCG Holdings
New York
$24K
2
Millennium Management
2
Millennium Management
New York
$340K
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$0
4
PAG
4
Private Advisor Group
New Jersey
$0
5
PNC Financial Services Group
5
PNC Financial Services Group
Pennsylvania
$0
Name Market Value Shares Shares
Change 		Shares
Change %
PAG
26
Private Advisor Group
New Jersey
– – -15,000 Closed
PNC Financial Services Group
27
PNC Financial Services Group
Pennsylvania
– – -10,000 Closed
Citigroup
28
Citigroup
New York
– – -1,105 Closed
1
2